Perrigo Anticipates FTC Settlement Will Resolve Ibuprofen Investigation
This article was originally published in The Tan Sheet
Executive Summary
Perrigo has recorded a $4.7 mil. charge in its fiscal fourth quarter in anticipation of settling a Federal Trade Commission investigation related to an ibuprofen product
You may also be interested in...
FTC Settlement May Portend Antitrust Scrutiny Of ANDA First-Filer Deals
The Federal Trade Commission's settlement with Perrigo and Alpharma suggests that deals struck between competing first-to-file generic drug manufacturers may trigger future antitrust scrutiny
FTC Settlement May Portend Antitrust Scrutiny Of ANDA First-Filer Deals
The Federal Trade Commission's settlement with Perrigo and Alpharma suggests that deals struck between competing first-to-file generic drug manufacturers may trigger future antitrust scrutiny
FTC Settlement May Portend Antitrust Scrutiny Of ANDA First-Filer Deals
The Federal Trade Commission's settlement with Perrigo and Alpharma suggests that deals struck between competing first-to-file generic drug manufacturers may trigger future antitrust scrutiny